Omadacycline for treatment of acute bacterial infections: a meta-analysis of phase II/III trials

Omadacycline for treatment of acute bacterial infections: a meta-analysis of phase II/III trials

Abstract Objective This study aims to assess the clinical efficacy and safety of omadacycline for the treatment of acute bacterial infections. Methods A search of PubMed, Embase, Cochrane Library, and Clinical Trials was conducted up to July 1, 2022. We included only randomized controlled trials (RC...

Full description

Bibliographic Details
Main Authors:	Fei Lin, Rong He, Bin Yu, Bowen Deng, Baodong Ling, Mingyong Yuan
Format:	Article
Language:	English
Published:	BMC 2023-04-01
Series:	BMC Infectious Diseases
Subjects:	Omadacycline Acute bacterial infections Meta-analysis, Efficacy, Safety
Online Access:	https://doi.org/10.1186/s12879-023-08212-0

Similar Items

Omadacycline in the treatment of community-acquired bacterial pneumonia in patients with comorbidities: a post-hoc analysis of the phase 3 OPTIC trial
by: George D. Rodriguez, et al.
Published: (2023-07-01)

Omadacycline for the treatment of Mycobacterium abscessus infections: Case series and review of the literature
by: Ayesha Siddiqa, et al.
Published: (2023-01-01)

Effect of omadacycline alone and in combination with meropenem against carbapenem-resistant Acinetobacter baumannii isolates
by: J. Nicholas O'Donnell, et al.
Published: (2022-06-01)

Empiric treatment approach for the management of post-operative incisional infections with omadacycline
by: Philip Wrotslavsky
Published: (2023-01-01)

Omadacycline Is Highly Active In Vitro against Mycoplasma genitalium
by: Ken B. Waites, et al.
Published: (2022-12-01)

Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity In Vitro
by: Anqi Li, et al.
Published: (2023-06-01)

Surveillance of omadacycline activity tested against clinical isolates from the USA: report from the SENTRY Antimicrobial Surveillance Program, 2019
by: Michael A. Pfaller, et al.
Published: (2021-12-01)

Re-establishing the utility of tetracycline-class antibiotics for current challenges with antibiotic resistance
by: Kerry L. LaPlante, et al.
Published: (2022-12-01)

Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease
by: Binayak Rimal, et al.
Published: (2023-04-01)

Omadacycline for the treatment of severe pneumonia caused by Chlamydia psittaci complicated with acute respiratory distress syndrome during the COVID-19 pandemic
by: Dao-Xin Wang, et al.
Published: (2024-01-01)

Omadacycline: A Newly Approved Antibacterial from the Class of Tetracyclines
by: Fernando Durães, et al.
Published: (2019-04-01)

Efficacy and safety of omadacycline for treating complicated skin and soft tissue infections: a meta-analysis of randomized controlled trials
by: Wenxin Liang, et al.
Published: (2024-02-01)

Omadacycline in first-line combination therapy for pulmonary Mycobacterium abscessus infection: a case series
by: Marylene Duah, et al.
Published: (2022-09-01)

Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility
by: Taylor Abbey, et al.
Published: (2022-06-01)

Novel Tetracyclines Versus Alternative Antibiotics for Treating Acute Bacterial Infection: A Meta-Analysis of Randomized Controlled Trials
by: Shao-Huan Lan, et al.
Published: (2019-11-01)

Antimicrobial activity of omadacycline in vitro against bacteria isolated from 2014 to 2017 in China, a multi-center study
by: Meng Xiao, et al.
Published: (2020-11-01)

The Novel Aminomethylcycline Omadacycline Has High Specificity for the Primary Tetracycline-Binding Site on the Bacterial Ribosome
by: Corina G. Heidrich, et al.
Published: (2016-09-01)

Omadacycline dihydrate, C29H40N4O7·2H2O, from X-ray powder diffraction data
by: James A. Kaduk, et al.
Published: (2024-03-01)

AdeABC Efflux Pump Controlled by AdeRS Two Component System Conferring Resistance to Tigecycline, Omadacycline and Eravacycline in Clinical Carbapenem Resistant Acinetobacter nosocomialis
by: Yi-Tzu Lee, et al.
Published: (2020-11-01)

In Vitro Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria
by: Tingting Zhang, et al.
Published: (2023-02-01)

Omadacycline for management of Mycobacterium abscessus infections: a review of its effectiveness, place in therapy, and considerations for use
by: Ashley R. Rizzo, et al.
Published: (2022-11-01)

Omadacycline for the Treatment of Severe Chlamydia psittaci Pneumonia Complicated with Guillain-Barre Syndrome
by: Wang J, et al.
Published: (2024-01-01)

In vitro Activity and Heteroresistance of Omadacycline Against Clinical Staphylococcus aureus Isolates From China Reveal the Impact of Omadacycline Susceptibility by Branched-Chain Amino Acid Transport System II Carrier Protein, Na/Pi Cotransporter Family Protein, and Fibronectin-Binding Protein
by: Bing Bai, et al.
Published: (2019-11-01)

In vitro antimicrobial activity and resistance mechanisms of the new generation tetracycline agents, eravacycline, omadacycline, and tigecycline against clinical Staphylococcus aureus isolates
by: Weiliang Zeng, et al.
Published: (2022-11-01)

Case Report: Omadacycline in the treatment of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in an adolescent patient
by: Limin Xu, et al.
Published: (2023-09-01)

Omadacycline for the Treatment of Severe Chlamydia psittaci Pneumonia Complicated with Multiple Organ Failure: A Case Report
by: Fang C, et al.
Published: (2022-10-01)

In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020
by: Po-Yu Liu, et al.
Published: (2022-10-01)

Activity of omadacycline in vitro against Clostridioides difficile and preliminary efficacy assessment in a hamster model of C. difficile-associated diarrhoea
by: Raina Gay Leahy, et al.
Published: (2022-09-01)

Potential Cost Savings Associated with Targeted Substitution of Current Guideline-Concordant Inpatient Agents with Omadacycline for the Treatment of Adult Hospitalized Patients with Community-Acquired Bacterial Pneumonia at High Risk for <i>Clostridioides difficile</i> Infections: Results of Healthcare-Decision Analytic Model from the United States Hospital Perspective
by: Thomas Lodise, et al.
Published: (2021-10-01)

The efficacy and adverse events of delafloxacin in the treatment of acute bacterial infections: A systematic review and meta-analysis of randomized controlled trials
by: Rong He, et al.
Published: (2022-09-01)

Efficacy and Safety of COVID-19 Vaccines in Phase III Trials: A Meta-Analysis
by: Haoyue Cheng, et al.
Published: (2021-06-01)

Acute bacterial skin and soft tissue infections: new drugs in ID armamentarium
by: Raghavendra Tirupathi, et al.
Published: (2019-07-01)

In Vitro Activity of Omadacycline and Comparator Antibiotics against Extended-Spectrum Beta-Lactamase-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> Urinary Isolates
by: Tyler J. Stone, et al.
Published: (2023-05-01)

Use of Oral Tetracyclines in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia: A Literature Review on the Often-Overlooked Antibiotic Class
by: Monique R. Bidell, et al.
Published: (2020-12-01)

Evaluation of Neisseria gonorrhoeae Isolates Susceptibility to Tetracycline Antibiotics from 9 Provinces in China Since 2020
by: Zhou Q, et al.
Published: (2022-03-01)

Clinical efficacy and safety of rimegepant in the treatment of migraine: a meta-analysis of randomized controlled trials
by: Qinghui Wang, et al.
Published: (2023-06-01)

Efficacy and safety of glucocorticoid in the treatment of sepsis: A systematic review and meta-analysis
by: Hua Zou, et al.
Published: (2023-07-01)

Emergence of mobile tigecycline resistance mechanism in Escherichia coli strains from migratory birds in China
by: Chong Chen, et al.
Published: (2019-01-01)

In Vitro Activity of KBP-7072 against 536 Acinetobacter baumannii Complex Isolates Collected in China
by: Renru Han, et al.
Published: (2022-02-01)

Efficacy and safety of intraocular implants: a Meta-analysis
by: Ren-Liang Huang, et al.
Published: (2016-07-01)